2023-12-01 08:31:39 ET
- Neximmune ( NEXI ) +338% .
- Jeffs Brands ( JFBR ) +64% Received Regulatory Approvals in Spain and The Netherlands to Commence Sales.
- ShiftPixy ( PIXY ) +26% .
- Altimmune ( ALT ) +38% pulls back from twice-daily regime of weight-loss drug candidate.
- Biora Therapeutics ( BIOR ) +29% clears Biora to begin Phase 1 testing of ulcerative colitis treatment.
- Sigma Additive Solutions ( SASI ) +31% .
- Clearmind Medicine ( CMND ) +22% .
- Elastic ( ESTC ) +18% Q2 earnings call reease
- Fenbo Holdings Limited ( FEBO ) +17% .
- UiPath ( PATH ) +15% .
- Samsara ( IOT ) +13% .
- Ulta Beauty ( ULTA ) +11% .
- GigaCloud Technology ( GCT ) +9% Q3 earnings call release
- Canaan ( CAN ) +3% .
- Pagerduty ( PD ) +6% Q3 earnings call release
- Taoping ( TAOP ) +6% .
- Hongli Group ( HLP ) +6% .
- Soho House ( SHCO ) +5% .
For further details see:
PATH, ULTA and CAN are among pre market gainers